» Articles » PMID: 30776063

Heritability of Cerebral Blood Flow and the Correlation to Schizophrenia Spectrum Disorders: A Pseudo-continuous Arterial Spin Labeling Twin Study

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2019 Feb 19
PMID 30776063
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Whether aberrant cerebral blood flow (CBF) in schizophrenia is affected by genetic influences, and consequently a potential marker for genetic susceptibility, is unknown. Our aims were to determine the heritability of CBF in thalamic, frontal, and striatal areas, and to ascertain if associations with disease were under genetic influence. Monozygotic (MZ) twin pairs concordant (n = 2) or discordant (n = 20) for schizophrenia spectrum disorders (ICD-10 F2x.x), matched on sex and age with dizygotic (DZ; n = 20) and healthy control pairs (MZ: n = 27; DZ: n = 18; total: n = 181 individuals), were recruited via the National Danish Twin Register. CBF in thalamus, frontal lobes, and putamen was measured with pseudo-continuous arterial spin labeling on a 3 T magnetic resonance scanner. Twin statistics were performed with structural equation modeling. CBF in the frontal lobes was heritable (h2 = 0.44, 95% CI [0.22-0.60]) but not correlated to disease. CBF correlated to schizophrenia spectrum disorders in the left thalamus (r = 0.17, [0.03-0.31]; P = 0.02), as well as in the left putamen (r = 0.19, [0.05-0.32]; P = 0.007) and the right putamen (r = 0.18, [0.03-0.32]; P = 0.02). When restricting the sample to schizophrenia (F20.x) only, shared genetic influences between CBF in the left putamen and schizophrenia liability (phenotypic correlation = 0.44, [0.28-0.58], P < 0.001) were found. Our results provide heritability estimates of CBF in the frontal lobes, and we find CBF in thalamus and putamen to be altered in schizophrenia spectrum disorders. Furthermore, shared genetic factors influence schizophrenia liability and striatal perfusion. Specifically, higher perfusion in the left putamen may constitute a marker of genetic susceptibility for schizophrenia.

Citing Articles

Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk.

Davies C, Bossong M, Martins D, Wilson R, Appiah-Kusi E, Blest-Hopley G Schizophr Bull Open. 2024; 4(1):sgad022.

PMID: 39145348 PMC: 11207663. DOI: 10.1093/schizbullopen/sgad022.


Reward Processing as an Indicator of Vulnerability or Compensatory Resilience in Psychoses? Results From a Twin Study.

Nielsen M, Rostrup E, Hilker R, Legind C, Anhoj S, Robbins T Biol Psychiatry Glob Open Sci. 2023; 3(1):47-55.

PMID: 36712565 PMC: 9874133. DOI: 10.1016/j.bpsgos.2022.01.002.


Reduced cortical cerebral blood flow in antipsychotic-free first-episode psychosis and relationship to treatment response.

Selvaggi P, Jauhar S, Kotoula V, Pepper F, Veronese M, Santangelo B Psychol Med. 2022; 53(11):5235-5245.

PMID: 36004510 PMC: 10476071. DOI: 10.1017/S0033291722002288.


Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol.

Sandstrom K, Baltzersen O, Marsman A, Lemvigh C, Boer V, Bojesen K Front Psychiatry. 2022; 13:889572.

PMID: 35669271 PMC: 9163784. DOI: 10.3389/fpsyt.2022.889572.


Brain features of nearly drug-naïve female monozygotic twins with first-episode schizophrenia and the classification accuracy of brain feature patterns: A pilot study.

Zhang T, Song J, Chen C, Li R, Li Y, Sun Y Brain Behav. 2020; 11(2):e01992.

PMID: 33295156 PMC: 7882158. DOI: 10.1002/brb3.1992.

References
1.
Andreasen N, OLeary D, Flaum M, Nopoulos P, WATKINS G, Boles Ponto L . Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet. 1997; 349(9067):1730-4. DOI: 10.1016/s0140-6736(96)08258-x. View

2.
Buchsbaum M, Hazlett E . Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull. 1998; 24(3):343-64. DOI: 10.1093/oxfordjournals.schbul.a033331. View

3.
Theberge J . Perfusion magnetic resonance imaging in psychiatry. Top Magn Reson Imaging. 2009; 19(2):111-30. DOI: 10.1097/RMR.0b013e3181808140. View

4.
Lahti A, Weiler M, Holcomb H, Tamminga C, Cropsey K . Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology. 2009; 34(13):2675-90. PMC: 2784027. DOI: 10.1038/npp.2009.94. View

5.
Miller D, Andreasen N, OLeary D, Rezai K, WATKINS G, Ponto L . Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology. 1997; 17(4):230-40. DOI: 10.1016/S0893-133X(97)00042-0. View